Fri, Feb 27, 2015, 5:23 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kyjellie kyjellie Jul 2, 2012 1:55 PM Flag

    SGI-110

    Right of First Offer:

    I believe this means that if ASTX decides to partner this drug, that they have to first offer it to Eisai. Eisai would have 3-6 months to decide an a deal or pass on it.

    It would be nice to see astx actually get a drug under their full control. This is maybe why they hint about the credit line they have? What would a deal look like today on this compound? They could asked for more upfront and take less on the royalities. Something like $500M (just a number) with milestones and a 15%+ royality?

    Could they get this drug approved on their own? This would be the best case for investors. If sgi-110 is the real deal and gained a good chunk of the market, $500M in sales, this would maybe have a solid $1.50 EPS, at a PE of 15(conservative), we're looking at $20+ a share. We can dream.

    As long as SGI-110 performs, Dr. M is in the driver seat. The thing he does real well, is these kind of deals. Look at Nipent. With Dacogen they were cash poor, they got a softer deal, than what could be expected today.

 
ASTX
8.4950.0000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.